Solesence, Inc. Common Stock (SLSN) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Solesence, Inc. Common Stock stock (SLSN) is currently trading at $0.90. Solesence, Inc. Common Stock PE ratio is 85.84. Solesence, Inc. Common Stock PS ratio (Price-to-Sales) is 0.97. WallStSmart rates SLSN as Sell.
- SLSN PE ratio analysis and historical PE chart
- SLSN PS ratio (Price-to-Sales) history and trend
- SLSN intrinsic value — DCF, Graham Number, EPV models
- SLSN stock price prediction 2025 2026 2027 2028 2029 2030
- SLSN fair value vs current price
- SLSN insider transactions and insider buying
- Is SLSN undervalued or overvalued?
- Solesence, Inc. Common Stock financial analysis — revenue, earnings, cash flow
- SLSN Piotroski F-Score and Altman Z-Score
- SLSN analyst price target and Smart Rating
Solesence, Inc.
📊 No data available
Try selecting a different time range
SLSN Intrinsic Value Analysis for Value Investors
Benjamin Graham Formula · Solesence, Inc. Common Stock (SLSN)
SLSN trades 1757% above its Graham fair value of $0.07, indicating the stock may be overvalued at current levels.
Based on Benjamin Graham Formula. Growth rate capped at 25%. For informational purposes only. Not financial advice.
Smart Analysis
Solesence, Inc. Common Stock (SLSN) · 9 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in price/sales. Concerns around market cap and return on equity. Significant fundamental concerns warrant caution or avoidance.
Solesence, Inc. Common Stock (SLSN) Key Strengths (1)
Paying less than $1 for every $1 of annual revenue
Supporting Valuation Data
Solesence, Inc. Common Stock (SLSN) Areas to Watch (8)
Losing money on operations
Revenue declining -13.50%, a shrinking business
Earnings declining -93.50%, profits shrinking
Very thin margins, barely profitable
Very low institutional interest at 6.26%
Micro-cap company with very limited liquidity and high volatility
Low profitability relative to shareholder equity
Premium pricing at 3.6x book value
Supporting Valuation Data
Solesence, Inc. Common Stock (SLSN) Detailed Analysis Report
Overall Assessment
This company scores 26/100 in our Smart Analysis, earning a F grade. Out of 9 metrics analyzed, 1 register as strengths (avg 10.0/10) while 8 fall into concern territory (avg 1.8/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Price/Sales. Valuation metrics including Price/Sales (0.97) suggest the stock is attractively priced.
The Bear Case
The primary concerns are Operating Margin, Revenue Growth, EPS Growth. Some valuation metrics including Price/Book (3.60) suggest expensive pricing. Growth concerns include Revenue Growth at -13.50%, EPS Growth at -93.50%, which may limit upside. Profitability pressure is visible in Return on Equity at 6.60%, Operating Margin at -5.35%, Profit Margin at 1.72%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Operating Margin improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at 6.60% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at -13.50% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. Operating Margin and Revenue Growth are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
SLSN Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
SLSN's Price-to-Sales ratio of 0.97x trades 16% below its historical average of 1.16x (0th percentile). The current valuation is 33% below its historical high of 1.45x set in Mar 2026, and 0% above its historical low of 0.97x in Mar 2026. Over the past 12 months, the PS ratio has compressed from ~1.5x as trailing revenue scaled faster than the stock price.
Compare SLSN with Competitors
Top HOUSEHOLD & PERSONAL PRODUCTS stocks by market cap
Compare any two stocks →WallStSmart Analysis Synopsis
Data-driven financial summary for Solesence, Inc. Common Stock (SLSN) · CONSUMER DEFENSIVE › HOUSEHOLD & PERSONAL PRODUCTS
The Big Picture
Solesence, Inc. Common Stock faces headwinds with declining revenue, though profitability provides a cushion. Revenue reached 62M with 14% decline year-over-year. Profit margins are strong at 172.0%, reflecting pricing power and operational efficiency.
Key Findings
ROE of 660.0% means the company generates strong returns on shareholder equity. Above 20% is considered top-tier.
Revenue contracted 14% YoY. Worth determining whether this is cyclical or structural.
Free cash flow is -3M, meaning the company is burning cash. This may be acceptable for high-growth companies investing heavily.
What to Watch Next
Valuation compression risk at a P/E of 85.8x. Any growth miss could trigger a sharp correction.
Sector dynamics: monitor HOUSEHOLD & PERSONAL PRODUCTS industry trends, competitive moves, and regulatory changes that could impact Solesence, Inc. Common Stock.
Bottom Line
Solesence, Inc. Common Stock faces challenges with declining revenue. While profitability provides a buffer, the long-term trajectory needs to improve. Watch for management's strategic response and whether the company can stabilize or pivot to new growth drivers.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Loading insider activity...
About Solesence, Inc. Common Stock(SLSN)
NASDAQ
CONSUMER DEFENSIVE
HOUSEHOLD & PERSONAL PRODUCTS
USA
Solesence, Inc., a science-driven company, develops, manufactures, and sells integrated family of technologies in the United States. The company is headquartered in Romeoville, Illinois.